Absence of CD80 reduces HSV-1 replication in the eye and delays reactivation but not latency levels
Journal of Virology · 2024
DOI: 10.1128/jvi.02010-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Ujjaldeep Jaggi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, Cedars-Sinai Burns and Allen Research Institute, Los …. Hauptthemen laut MEDLINE: Eye Infections, Herpes Simplex, Herpesvirus 1, Human. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, HHS | NIH | National Eye Institute.
Abstract (Originalsprache)
Herpes simplex virus-1 (HSV-1) infections are among the most frequent serious viral eye infections in the U.S. and are a major cause of viral-induced blindness. HSV-1 infection is known to induce T cell activation, proliferation, and differentiation that play crucial roles in the development of virus-induced inflammatory lesions, leading to eye disease and causing chronic corneal damage. CD80 is a co-stimulatory molecule and plays a leading role in T cell differentiation. Previous efforts to limit lesion severity by controlling inflammation at the cellular level led us to ask whether mice knocked out for CD80 would show attenuated virus replication following reactivation. By evaluating the effects of CD80 activity on primary and latent infection, we found that in the absence of CD80, virus replication in the eyes and virus reactivation in latent trigeminal ganglia were both significantly reduced. However, latency in latently infected CD80 −/− mice did not differ significantly from that in wild-type (WT) control mice. Reduced virus replication in the eyes of CD80 −/− mice correlated with significantly expanded CD11c gene expression as compared to WT mice. Taken together, our results indicate that suppression of CD80 could offer significant beneficial therapeutic effects in the treatment of Herpes Stromal Keratitis (HSK). IMPORTANCE Of the many problems associated with recurrent ocular infection, reducing virus reactivation should be a major goal of controlling ocular herpes simplex virus-1 (HSV-1) infection. In this study, we have shown that the absence of CD80 reduces HSV-1 reactivation, which marks the establishment of a previously undescribed mechanism underlying viral immune evasion that could be exploited to better manage HSV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, Cedars-Sinai Burns and Allen Research Institute, Los Angeles, California, USA.
ORCID-Profile: Ujjaldeep Jaggi, Jay J Oh, Homayon Ghiasi
Förderung
- NEI NIH HHS
- HHS | NIH | National Eye Institute
Zitieren
APA
Jaggi, U., Matundan, H. H., Oh, J. J., & Ghiasi, H. (2024). Absence of CD80 reduces HSV-1 replication in the eye and delays reactivation but not latency levels. Journal of Virology. https://doi.org/10.1128/jvi.02010-23
Vancouver
Jaggi U, Matundan HH, Oh JJ, Ghiasi H. Absence of CD80 reduces HSV-1 replication in the eye and delays reactivation but not latency levels. Journal of Virology. 2024. doi:10.1128/jvi.02010-23
BibTeX
@article{Jaggi2024,
author = {Jaggi, Ujjaldeep and Matundan, Harry H and Oh, Jay J and Ghiasi, Homayon},
title = {Absence of CD80 reduces HSV-1 replication in the eye and delays reactivation but not latency levels},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.02010-23}
}
EUVIMED